Kidney Cancer Coverage from Every Angle

Sumanta K. Pal, MD, on Renal Cancer Immunotherapy: Latest Developments

Posted: Sunday, January 28, 2018

Sumanta K. Pal, MD, of the City of Hope, discusses immunotherapy for kidney cancer as a front-line treatment and the strategy of VEGF blockade with immunotherapy, which is emerging as a possible treatment modality.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.